Targeted Oncology: Risk of Recurrent Colorectal Cancer Following Definitive Therapy
· Education
In this Targeted Oncology video, Dr. Yoshiaki Nakamur discusses the utility of tissue-free ctDNA testing to predict recurrence in CRC patients.
Get notified of new trials and updates
One email when something new is posted: a new clinical trial, meeting highlights, or educational material. No spam, unsubscribe any time.
Prefer a reader? Use the RSS feed.